Providing Consistency for Apheresis Starting Material for Autologous CAR-T Manufacturing through Cryopreservation

Time: 11:05 am
day: Agenda: Next Generation of Cell Therapies: Combined Analytics & Cryopreserved Starting Materials


  • Use of cryopreservation to allow for flexibility in logistics/scheduling
  • Bringing consistency to starting material across variable patient populations through a standard cryopreservation process